HG
Publicaties op Oncologisch.com
US Food and Drug Administration Approval Summary: Ribociclib With an Aromatase Inhibitor in the Adjuvant Hormone Rece...
US Food and Drug Administration Approval Summary: Inavolisib With Palbociclib and Fulvestrant for Endocrine-Resistant...
FDA-goedkeuring van elacestrant bij ESR1-gemuteerd mammacarcinoom
FDA-goedkeuring van lutetium-177-vipivotide tetraxetan bij mCRPC